Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
Phaedon D. Zavras, Ilias Sinanidis, Panagiotis Tsakiroglou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5018-5018
Open Access | Times Cited: 11

Showing 11 citing articles:

Recent advances in endothelial colony-forming cells: from the transcriptomic perspective
Yaqiong Liu, Caomhán J. Lyons, Christine Ayu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Latest Insights and Therapeutic Advances in Myelodysplastic Neoplasms
Pasquale Niscola, Valentina Gianfelici, Marco Giovannini, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1563-1563
Open Access | Times Cited: 7
Efficacy and safety of decitabine combined with arsenic trioxide in elderly high-risk myelodysplastic neoplasm patients: a retrospective study
Jianzhong Yang
Hematology (2025) Vol. 30, Iss. 1
Open Access
Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis
Yufeng Du, Chunhong Li, Zhijia Zhao, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
Theodora Chatzilygeroudi, Vasiliki Chondrou, Ruben Boers, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition
Valentina Giudice, Bianca Serio, Santa Errichiello, et al.
European Journal Of Haematology (2023) Vol. 111, Iss. 5, pp. 729-741
Open Access | Times Cited: 3
Acute Myeloid Leukemia Arising from Myelodysplastic Syndromes
Adelaide Kwon, Olga K. Weinberg
Clinics in Laboratory Medicine (2023) Vol. 43, Iss. 4, pp. 657-667
Closed Access | Times Cited: 3
Diagnosis of erythroid dysplasia by flow cytometry: a review
Marc Sorigué
Expert Review of Hematology (2023) Vol. 16, Iss. 12, pp. 1049-1062
Open Access | Times Cited: 1
SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes
Michael J. Hochman, Amy E. DeZern
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 9, pp. 573-582
Closed Access
Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
Theodora Chatzilygeroudi, Vasiliki Chondrou, Ruben Boers, et al.
Research Square (Research Square) (2024)
Open Access
Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post-transplantation: a systematic review and meta-analysis
Yufeng Du, Chunhong Li, Cheng-Tao Zhang, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top